Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-β treatment

Ferdinando Nicoletti, Francesco Patti, Roberto Di Marco, Paola Zaccone, Alessandra Nicoletti, PierLuigi Meroni, Arturo Reggio

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-β treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds